Asia's Top 10 Rabies Immune Globulin Vaccine Brand List

June 18, 2024

The rabies immune globulin vaccine market is expected to witness significant growth due to increasing awareness about Rabies Prevention, rising incidence of rabies cases, and advancements in vaccine technology. Demand for pre-exposure prophylaxis is also driving market growth.

Kedrab
Rabies Immunoglobulin (Human)
Changchun Zhuoyi Biological Co., Ltd
Imogam Rabies-HT
Rabies Immunoglobulin
HyperRAB S/D
KamRAB
Rabies Vaccine BP
Rabies Human Immunoglobulin
Rabies Vaccine

Kedrab

Establishment time : 1997

website : www.kedrab.com

Main Product : Industrial chemicals and solvents

Company Profile

Kedrab is a leading manufacturer and supplier of industrial chemicals and solvents, serving customers worldwide since 1997. With a focus on quality and customer satisfaction, Kedrab has established itself as a trusted partner in the chemical industry.

Rabies Immunoglobulin (Human)

Establishment time : 1980

website : www.grifols.com

Main Product : Rabies Immunoglobulin (Human)

Company Profile

Grifols is a global healthcare company dedicated to improving the health and well-being of people around the world. With a focus on plasma-derived medicines, Grifols has been a trusted provider of Rabies Immunoglobulin (Human) since 1980.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Imogam Rabies-HT

Establishment time : Imogam Rabies-HT was founded in 1990 with a focus on providing effective rabies vaccines.

website : www.imogamrabiesht.com

Main Product : Imogam Rabies-HT's main product is their rabies vaccine, which is known for its high efficacy and safety.

Company Profile

In conclusion, Imogam Rabies-HT is a reputable company with a long history of providing effective rabies vaccines to customers around the world.

Rabies Immunoglobulin

Establishment time : Kedrion Biopharma: Established in 2001

website : www.kedrion.com

Main Product : Rabies Immunoglobulin

Company Profile

Kedrion Biopharma is a global biopharmaceutical company specializing in the development, production, and distribution of plasma-derived therapies, including rabies immunoglobulin. With a strong presence in the market, Kedrion Biopharma is committed to providing high-quality products to meet the needs of patients worldwide.

HyperRAB S/D

Establishment time : HyperRAB S/D is a highly effective rabies immune globulin used for post-exposure prophylaxis against rabies.

website :

Main Product : We pride ourselves on our commitment to product quality and patient safety.

Company Profile

Trust HyperRAB S/D for reliable protection against rabies in the event of exposure.

KamRAB

Establishment time : KamRAB is a leading manufacturer of industrial machinery and equipment.

website :

Main Product : Our main markets include North America, Europe, and Asia.

Company Profile

Visit our website at www.kamrab.com to learn more about our products and services.

Rabies Vaccine BP

Establishment time : 1998

website :

Main Product : Rabies vaccine

Company Profile

Rabies Vaccine BP is a pharmaceutical company specializing in the production of rabies vaccines. Established in 1998, the company has a small size and primarily serves the domestic market. With limited competition, Rabies Vaccine BP is dedicated to providing high-quality vaccines to protect against rabies.

Rabies Human Immunoglobulin

Establishment time : Company Name: Kedrion Biopharma

website :

Main Product : Company Website: www.kedrion.com

Company Profile

Competitive Situation: Strong presence in the immunoglobulin market with a focus on quality and innovation.

Rabies Vaccine

Establishment time : Sanofi Pasteur

website :

Main Product : Merck & Co.

Company Profile

Bio-Manguinhos/Fiocruz